Detalles de la búsqueda
1.
A prospective, real-world, multinational study of febrile neutropenia (FN) occurrence in oncology patients receiving chemotherapy with intermediate risk of FN: a MASCC Neutropenia, Infection, and Myelosuppression Study Group initiative.
Support Care Cancer
; 31(12): 628, 2023 Oct 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-37828258
2.
Dysregulation of systemic soluble immune checkpoints in early breast cancer is attenuated following administration of neoadjuvant chemotherapy and is associated with recovery of CD27, CD28, CD40, CD80, ICOS and GITR and substantially increased levels of PD-L1, LAG-3 and TIM-3.
Front Oncol
; 13: 1097309, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37064132
3.
Tumor-Infiltrating Lymphocytes (TILs) in Early Breast Cancer Patients: High CD3+, CD8+, and Immunoscore Are Associated with a Pathological Complete Response.
Cancers (Basel)
; 14(10)2022 May 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-35626126
4.
Systemic Immune Dysregulation in Early Breast Cancer Is Associated With Decreased Plasma Levels of Both Soluble Co-Inhibitory and Co-Stimulatory Immune Checkpoint Molecules.
Front Immunol
; 13: 823842, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35677046
5.
High Mobility Group Box 1 in Human Cancer.
Cells
; 9(7)2020 07 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-32664328
Resultados
1 -
5
de 5
1
Próxima >
>>